These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1939964

  • 1. Creation of the recombinant tissue plasminogen activator (rt-PA) image and its influence on practice habits.
    Sherry S, Marder VJ.
    J Am Coll Cardiol; 1991 Nov 15; 18(6):1579-82. PubMed ID: 1939964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E, Degli Esposti D.
    Cardiologia; 1991 Dec 15; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
    Held PH, Teo KK, Yusuf S.
    Circulation; 1990 Nov 15; 82(5):1668-74. PubMed ID: 2146038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW, Zeitler R, Fitzpatrick P.
    Clin Cardiol; 1993 Apr 15; 16(4):283-92. PubMed ID: 8458108
    [Abstract] [Full Text] [Related]

  • 13. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U, Tebbe U, Essen Rv, Haarmann W, Neuhaus KL.
    Am Heart J; 1999 Jan 15; 137(1):34-8. PubMed ID: 9878934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL.
    N Engl J Med; 1995 May 25; 332(21):1418-24. PubMed ID: 7723799
    [Abstract] [Full Text] [Related]

  • 17. Designing thrombolytic agents: focus on safety and efficacy.
    Collen D.
    Am J Cardiol; 1992 Jan 03; 69(2):71A-81A. PubMed ID: 1729881
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thrombolytic, antiplatelet, and antithrombotic agents.
    Grines CL.
    Am J Cardiol; 1992 Dec 21; 70(21):18I-26I. PubMed ID: 1471601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.